Replies to post #523498 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

I consider this repeated number to be irrelevant to someone like myself who invested within the last year. We have approvals coming. The trial is actually done. The PIP is actually approved. Some will keep trying to make it sound like this is 2008 NWBO, but this is 2022. We can keep our head in the sand or realize the progress that has been made. I choose to keep my head out of the sand and acknowledge that it is 2022 and the progress that has been made.

Have a great one LIM.

[skitahoe]

I believe that if you examine what she's done while the stock price went down, then you can judge whether it's good, or bad.

I believe that NWBO is posed to make gains that will eventually take it to many times it's prior highs. If I'm right about that, keeping the company in business in spite of the reduction in share price will be celebrated by long term investors who today own far more stock than they had when it was trading near all time highs.

I frankly believe that many CEO's would have thrown in the towel years ago, the company, and the vaccine would have been considered a failure. I believe it won't just be a success, it may develop into a new paradigm in the treatment of nearly all solid cancers. I cannot say that some CEO might have not succeeded faster, or with less volatility in the stock, but I really believe that L.P. did a great job in dealing with the hand she was dealt and the fact that we're closing in on approvals is a tremendous endorsement of her skills. This has been going on for well over a decade, it's time to let it be successfully completed.

Gary